Organo Therapeutics
OrganoTherapeutics use mini-brains for the discovery and development of effective drug candidates targeting Parkinson’s disease.
Based based in European Union (EU), Europe, Middle East, and Africa (EMEA), Organo Therapeutics works in biopharma, biotechnology, life science, pharmaceutical, founded in 2019.
Its activity falls under biopharma, biotechnology, life science, pharmaceutical; the profile below is assembled from public directory data.
European Union (EU), Europe, Middle East, and Africa (EMEA) is where the company is located.
Directory data places it at the Seed stage.
Recorded headcount: c_00001_00010 employees.
| Sector | Biopharma, Biotechnology, Life Science, Pharmaceutical |
|---|---|
| Headquarters | European Union (EU), Europe, Middle East, and Africa (EMEA) |
| Founded | 2019 |
| Employees | c_00001_00010 |
| Stage | seed |
Website: organo-therapeutics.com
Browse related
Emails and contact routes are reserved for registered members.
Create a free account
Create a free account